Loading clinical trials...
Loading clinical trials...
A Multi-Center Phase II Trial of Individualized Adaptive De-escalated Radiotherapy Using Pre and Mid-Treatment FDG-PET/CT for HPV-related Oropharynx Cancer
Conditions
Interventions
Carboplatin
Radiation Therapy
+1 more
Locations
2
United States
University of Michigan Hospital
Ann Arbor, Michigan, United States
VA Ann Arbor Healthcare System
Ann Arbor, Michigan, United States
Start Date
May 21, 2018
Primary Completion Date
May 5, 2023
Completion Date
May 5, 2025
Last Updated
May 22, 2025
NCT05639972
NCT06563362
NCT06088381
NCT04178174
NCT05800574
NCT04277858
Lead Sponsor
University of Michigan Rogel Cancer Center
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions